Indications
Opulis is indicated for the relief of symptoms associated with:- allergic rhinitis (see section 5.1)- urticaria (see section 5.1)
Composition
- Active substance
- desloratadine
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Opulis
- Active substance
- desloratadine
- ATC code
- R06AX27
- Group
- Respiratory system
- Therapeutic area
- Rhinitis, Allergic, Perennial, Urticaria, Rhinitis, Allergic, Seasonal
- Marketing authorisation holder
- Schering-Plough Europe
- Status
- Withdrawn
- EU authorisation
- 15 Jan 2001